Clear Secure Stock Crushing: Why It Shook Markets Wednesday
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
Which Passive Funds Are Best Value For Retirement
Choosing the right passive funds can reduce costs and improve retirement outcomes. Explore Which Passive Funds Are Best Value For Retirement to find efficient options.
26,439 articles
This Fund Exited Million: A Cinemark Exit Analysis
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
There BDCs Paying Yields: Can They Sustain the High Payouts
Three BDCs flash double-digit yields, but sustainability varies. FSK and SCM face earnings pressure and dividend cuts...
UWM Rolls Mortgage Payment Rewards with Bilt Platform
United Wholesale Mortgage launches Built-In Rewards, a program that pays rewards points to borrowers for timely mortg...
Greg Abel Just Quietly Reshapes Berkshire Holdings
Greg Abel is quietly rebalancing Berkshire Hathaway’s equity book, moving away from U.S. financials and toward intern...
SpaceX IPO Sparks Hollywood-Style Future Vision for Markets
SpaceX outlines a bold public listing to finance lunar and Martian programs, as markets evaluate the risk of big loss...
Bosc 2026 Earnings Transcript: Q1 Deep Dive for Investors
A focused look at the BOSC 2026 earnings transcript for Q1. This article breaks down revenue trends, margin health, a...
Stellantis Counting This Brand to Soar in North America
Stellantis is betting big on a single brand to lift profits in North America. This strategic move centers on Ram and ...
Broadcom Builds Custom Chips: The Cheapest Mega-Cap AI Stock
While Nvidia grabs the spotlight with GPUs, Broadcom quietly powers AI at scale with custom accelerators. This articl...
Bears Scream That Falling Orders Miss Trend, Amazon Rises
Prime Day results defy pessimism as consumers keep shopping online and Amazon’s cloud growth supports the stock. The ...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
What This Synaptics Filing Signals Long-Term Investors
A recent CFO Form 4 shows a small share disposition at Synaptics while the company reports 10% revenue growth. This a...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status